Study objectives: To identify the predictors of medication adherence in patients with COPD and contrast the health beliefs, experiences, and behaviors of COPD patients self-reporting good ...
The importance of phenotyping chronic disease for personalized medicine Chronic diseases such as chronic obstructive pulmonary disease are due to a complex interaction of many genetic and ...
Mounting evidence from large randomised controlled trials suggests that COPD treatment may be cardio-protective. We review the current evidence supporting the aforementioned hypotheses and how their ...
UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year.
It's the first ever biologic medicine for COPD in either country. Specifically, the drug is indicated in both countries as an add-on treatment for patients with inadequately controlled COPD and an ...
USA 2 Department of Medicine, Oregon Health and Science University, Portland, Oregon, USA Objective: To determine morbidity and mortality among older adults whose FEV 1 /FVC is less than 0.70 but more ...